Synthetic vaccine found effective in killing HPV-derived cancer

Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived (HPV) cancer, a virus linked to cervical cancers among others.

The research was published in a recent issue of Cancer Immunology, Immunotherapy.

The authors of the study concluded, "We believe that these studies may help to launch more effective and less invasive therapeutic vaccines for HPV-caused malignancies."

Click here to read more from ScienceDaily.

Click here to read a report on HPV from the Centers of Disease Control and Prevention (CDC).